SARS-CoV-2 Beta B.1.351 Variant Recombinant Spike Trimer His Tag

Concentration-response curves for binding of CoV2 spike protein variant beta to human ACE2 in cell-free ELISA-type assays. Microtiter wells were coated with 100 uL of each spike trimer at 2 ug/mL in PBS at 4?C overnight. The wells were washed with PBS and blocked with 200 μL of 1% BSA/PBS. ACE2-Fc was serially diluted from 2 μg/mL in 1% BSA/PBS. The blocker was discarded, and the wells were incubated with 100 μL of serially diluted ACE2-Fc at 37?C for 1 hour. The wells were washed with PBS and the bound ACE2-Fc was detected with 100 μL of Peroxidase AffiniPure Goat Anti-Human IgG, Fc? fragment specific (1:5, 000 in 1% BSA/PBS) at 37?C for 1 hour. The wells were washed with PBS and the wells were developed with 100 μL of MB/E Ultra Sensitive, Blue, Horseradish Peroxidase Substrate at RT for 5 min. The reaction was stopped with 100 μL of 0.6N H2SO4 and the signals were read at 450 nm using a plate reader.

SARS-CoV-2 recombinant spike trimer His Tag protein (BETA| B.1.351) on SDS-PAGE under non-reducing (NR) and reducing (R) conditions. The gel was stained with Coomassie G-250 per manufacturer instructions. The purity of the protein is greater than 95% and it is between 175 and 270 kDa.